David Iser

2.0k total citations
55 papers, 1.4k citations indexed

About

David Iser is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Iser has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 43 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in David Iser's work include Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (31 papers). David Iser is often cited by papers focused on Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (31 papers). David Iser collaborates with scholars based in Australia, United States and New Zealand. David Iser's co-authors include Alexander Thompson, Paul Desmond, Sharon R. Lewin, Tin Nguyen, Stephen Locarnini, John Slavin, Edward Gane, Scott Bowden, Anna Ayres and Kumar Visvanathan and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

David Iser

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Iser Australia	20	1.2k	1.1k	183	74	68	55	1.4k
Chris Kassianides South Africa	16	1.4k 1.2×	1.5k 1.3×	213 1.2×	134 1.8×	39 0.6×	29	1.9k
Sarah Arterburn United States	19	2.3k 1.9×	2.3k 2.0×	398 2.2×	82 1.1×	35 0.5×	47	2.7k
Mauro Viganò Italy	27	2.4k 2.0×	2.2k 1.9×	285 1.6×	160 2.2×	24 0.4×	131	2.9k
Sabela Lens Spain	26	2.1k 1.8×	2.4k 2.1×	237 1.3×	205 2.8×	22 0.3×	119	2.7k
Benjamin Maasoumy Germany	25	1.5k 1.3×	1.7k 1.5×	305 1.7×	271 3.7×	27 0.4×	140	2.1k
Ayse Aytaman United States	14	694 0.6×	732 0.6×	55 0.3×	139 1.9×	20 0.3×	33	1.0k
B. Kallinowski Germany	20	1.1k 1.0×	1.3k 1.1×	129 0.7×	63 0.9×	37 0.5×	54	1.6k
Huy N. Trinh United States	31	2.2k 1.9×	2.0k 1.8×	302 1.7×	171 2.3×	22 0.3×	104	2.5k
Karl Barange France	18	1.2k 1.0×	1.4k 1.2×	173 0.9×	487 6.6×	141 2.1×	61	1.8k
Jeffrey Kahn United States	16	573 0.5×	562 0.5×	89 0.5×	369 5.0×	32 0.5×	48	960

Countries citing papers authored by David Iser

Since Specialization

Citations

This map shows the geographic impact of David Iser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Iser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Iser more than expected).

Fields of papers citing papers by David Iser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Iser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Iser. The network helps show where David Iser may publish in the future.

Co-authorship network of co-authors of David Iser

This figure shows the co-authorship network connecting the top 25 collaborators of David Iser. A scholar is included among the top collaborators of David Iser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Iser. David Iser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martinello, Marianne, Sanjay Bhagani, David Shaw, et al.. (2023). Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study. JHEP Reports. 5(10). 100867–100867. 4 indexed citations

Marukutira, Tafireyi, Margaret Hellard, Jacqui Richmond, et al.. (2023). Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners. International Journal of Drug Policy. 121. 104184–104184. 1 indexed citations

Dalgård, Olav, Alain H. Litwin, Oren Shibolet, et al.. (2022). Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection. Journal of Addictive Diseases. 41(3). 213–224. 3 indexed citations

Marukutira, Tafireyi, Margaret Hellard, Jacqui Richmond, et al.. (2022). Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol. BMJ Open. 12(3). e056120–e056120. 1 indexed citations

Hajarizadeh, Behzad, Josh Hanson, James O’Beirne, et al.. (2022). Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort. Journal of Viral Hepatitis. 29(8). 661–676. 9 indexed citations

Yee, Jasmine, Behzad Hajarizadeh, James O’Beirne, et al.. (2021). High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study. Hepatology Communications. 6(3). 496–512. 12 indexed citations

Hajarizadeh, Behzad, Josh Hanson, James O’Beirne, et al.. (2021). Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort. International Journal of Drug Policy. 96. 103422–103422. 16 indexed citations

McDonald, L, Anne Craigie, Paul Desmond, et al.. (2019). Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care. Journal of Hepatology. 70(5). 839–846. 82 indexed citations

Wade, Amanda, Joseph Doyle, Edward Gane, et al.. (2018). Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial. Trials. 19(1). 383–383. 6 indexed citations

10.

Nguyen, Tin, David Iser, Jacinta A. Holmes, et al.. (2017). Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World Journal of Hepatology. 9(1). 48–48. 19 indexed citations

11.

Thompson, Alexander, Britt Christensen, L McDonald, et al.. (2017). Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection. PLoS ONE. 12(10). e0185609–e0185609. 19 indexed citations

12.

Holmes, Julie, M Congiu, Sally Bell, et al.. (2015). The relationships between IFNL4 genotype, intrahepatic interferon‐stimulated gene expression and interferon treatment response differs in HCV‐1 compared with HCV‐3. Alimentary Pharmacology & Therapeutics. 42(3). 296–306. 10 indexed citations

13.

Molina, Jean‐Michel, Chloe Orkin, David Iser, et al.. (2015). Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. The Lancet. 385(9973). 1098–1106. 133 indexed citations

14.

Martinello, Marianne, Margaret Hellard, David Shaw, et al.. (2014). Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II Study. Hepatology. 60. 1 indexed citations

15.

Thompson, Alexander, Tin Nguyen, David Iser, et al.. (2010). Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers. Hepatology. 51(6). 1933–1944. 354 indexed citations

16.

Iser, David, Anchalee Avihingsanon, Naruemon Wisedopas, et al.. (2010). Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression. AIDS. 25(2). 197–205. 41 indexed citations

17.

Iser, David & Sharon R. Lewin. (2009). Treatment of hepatitis B virus (HBV) in the setting of HIV-HBV co-infection. Asian Biomedicine. 3(1). 15–27. 1 indexed citations

18.

Iser, David & Joseph Sasadeusz. (2008). Current treatment of HIV/hepatitis B virus coinfection. Journal of Gastroenterology and Hepatology. 23(5). 699–706. 24 indexed citations

19.

Iser, David, et al.. (2005). Gastrointestinal: Complications of colonoscopy. Journal of Gastroenterology and Hepatology. 20(8). 1301–1301. 8 indexed citations

20.

Rowley, Kevin, David Iser, James D. Best, et al.. (2000). Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia. 43(11). 1397–1403. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact